Lorina Vudu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lorina Vudu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Carolina Piterschi
Nicolae Testemitanu State University of Medicine and Pharmacy
4 shared publications - Stela Vudu
Nicolae Testemitanu State University of Medicine and Pharmacy
3 shared publications - Aristia Seremet2 shared publications
- Cristina Rizov2 shared publications
- Stela Bacinschi2 shared publications
Aurelia Bacinschi
IMSP CRDM
1 shared publication
Latest Publications
- 1 October 2025
- Published by Springer Nature
- p. 558-565
Image Acquisition and Analysis of Conjunctival Microvascular Network
- 1 October 2025
- Published by Springer Nature
- p. 558-565
Image Acquisition and Analysis of Conjunctival Microvascular Network
- 27 September 2025
- Published by Springer Nature
- p. 517-525
Ultrasound Assessment of Subcutaneous Adipose Tissue as a Predictor of Cardiometabolic Risk in Young Women
- 27 September 2025
- Published by Springer Nature
- p. 517-525
Ultrasound Assessment of Subcutaneous Adipose Tissue as a Predictor of Cardiometabolic Risk in Young Women
- 1 September 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (3) , 86-91
Osteocalcin and metabolic dysfunction in young women with obesity
Introduction. Osteocalcin, a bone-derived hormone, has emerged as a potential regulator of energy metabolism, with roles in insulin sensitivity, glucose homeostasis, and lipid metabolism. Although an inverse association between osteocalcin and body mass index has been previously reported, data on its link with metabolic parameters in young, otherwise healthy women with obesity remain limited. The objective of this study was to investigate the relationship between circulating osteocalcin levels and key metabolic parameters in this specific population. Material and methods. A cross-sectional observational study was conducted among 85 Caucasian women aged 18-45 years, without chronic disease or medication use. Participants were classified into two groups: normal weight (BMI 18.524.9 kg/m², n = 47) and with obesity (BMI ≥ 30 kg/m², n = 38). Anthropometric, hemodynamic, and biochemical parameters, including glucose, insulin, lipid profile, osteocalcin, and adiponectin, were assessed. Insulin resistance was evaluated using HOMA-IR and QUICKI. Group comparisons and Pearson correlation analyses were performed. Results. Osteocalcin levels were significantly lower in the group of women with obesity compared to the normal weight group (12.99 ± 4.7 vs. 19.75 ± 4.09 ng/mL, p less than 0.001). It was inversely correlated with BMI (r = - 0.56), waist-to-hip ratio, waist-to-height ratio, insulin, HOMA-IR, total and LDL cholesterol, and positively associated with QUICKI (r = 0.39) and adiponectin (r = 0.31) (all p less than 0.001). A progressive decline in osteocalcin levels was observed across obesity grades. Conclusions. Circulating osteocalcin is inversely associated with adiposity and metabolic dysfunction, suggesting its potential as an early biomarker of cardiometabolic risk in young women with obesity.
- 1 September 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (3) , 86-91
Osteocalcin and metabolic dysfunction in young women with obesity
Introduction. Osteocalcin, a bone-derived hormone, has emerged as a potential regulator of energy metabolism, with roles in insulin sensitivity, glucose homeostasis, and lipid metabolism. Although an inverse association between osteocalcin and body mass index has been previously reported, data on its link with metabolic parameters in young, otherwise healthy women with obesity remain limited. The objective of this study was to investigate the relationship between circulating osteocalcin levels and key metabolic parameters in this specific population. Material and methods. A cross-sectional observational study was conducted among 85 Caucasian women aged 18-45 years, without chronic disease or medication use. Participants were classified into two groups: normal weight (BMI 18.524.9 kg/m², n = 47) and with obesity (BMI ≥ 30 kg/m², n = 38). Anthropometric, hemodynamic, and biochemical parameters, including glucose, insulin, lipid profile, osteocalcin, and adiponectin, were assessed. Insulin resistance was evaluated using HOMA-IR and QUICKI. Group comparisons and Pearson correlation analyses were performed. Results. Osteocalcin levels were significantly lower in the group of women with obesity compared to the normal weight group (12.99 ± 4.7 vs. 19.75 ± 4.09 ng/mL, p less than 0.001). It was inversely correlated with BMI (r = - 0.56), waist-to-hip ratio, waist-to-height ratio, insulin, HOMA-IR, total and LDL cholesterol, and positively associated with QUICKI (r = 0.39) and adiponectin (r = 0.31) (all p less than 0.001). A progressive decline in osteocalcin levels was observed across obesity grades. Conclusions. Circulating osteocalcin is inversely associated with adiposity and metabolic dysfunction, suggesting its potential as an early biomarker of cardiometabolic risk in young women with obesity.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 24-30
Disfuncțiile glandei tiroide induse de medicamente
In recent decades a separate interest has been the study of the influence of drugs on thyroid function.The selection and analysis of scientific papers in the Pubmed database was carried out regarding the disorders of the function of the thyroid gland caused by drugs. It was found that the drugs are able to affect the function of the thyroid gland at the level of the hypothalamus-pituitary-thyroid axis, the synthesis, release, activation, metabolism and elimination of thyroid hormones, as well as to influence the effects of thyroid hormones at the cellular and systemic level. A wide range of drugs (iodine preparations, antiepileptics, antituberculosis drugs, monoclonal antibodies, glucocorticoids, antitumor drugs, estrogens, immunostimulatory cytokines, antacids, bile acid sequestrants, amiodarone, heparin, furosemide, etc.), have been identified, which can influence the function of the thyroid gland through different mechanisms. Drugs may induce subclinical or clinically manifest hypothyroidism or thyrotoxicosis. When examining the patient with suspected thyroid pathology, it is necessary to collect the anamnesis to highlight the drugs used as possible etiologic factors of thyroid dysfunction.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 24-30
Open AccessDisfuncțiile glandei tiroide induse de medicamente
In recent decades a separate interest has been the study of the influence of drugs on thyroid function.The selection and analysis of scientific papers in the Pubmed database was carried out regarding the disorders of the function of the thyroid gland caused by drugs. It was found that the drugs are able to affect the function of the thyroid gland at the level of the hypothalamus-pituitary-thyroid axis, the synthesis, release, activation, metabolism and elimination of thyroid hormones, as well as to influence the effects of thyroid hormones at the cellular and systemic level. A wide range of drugs (iodine preparations, antiepileptics, antituberculosis drugs, monoclonal antibodies, glucocorticoids, antitumor drugs, estrogens, immunostimulatory cytokines, antacids, bile acid sequestrants, amiodarone, heparin, furosemide, etc.), have been identified, which can influence the function of the thyroid gland through different mechanisms. Drugs may induce subclinical or clinically manifest hypothyroidism or thyrotoxicosis. When examining the patient with suspected thyroid pathology, it is necessary to collect the anamnesis to highlight the drugs used as possible etiologic factors of thyroid dysfunction.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 18-23
Managementul unui caz de hipotiroidism sever complicat cu efuziune pericardică masivă recidivantă în sindrom Down
Down’s syndrome is frequently associated with various endocrine dysfunctions, the most common being thyroid function disorders presented through a wide spectrum of manifestations, such as congenital and acquired hypothyroidism, especially the subclinical form, and less often hyperthyroidism. Symptoms of hypothyroidism are practically absent in subclinical forms, which requires regular screening for early detection of thyroid dysfunctions. We present of a clinical case from the Endocrinology Department of the „Timofei Moșneaga” Republican Clinical Hospital, successfully resolved following a multidisciplinary approach. The 25-year-old patient, diagnosed with Down syndrome since the age of 4, hospitalized in serious condition due to difficulty breathing, wet cough, dyspnea on moderate exertion, abdominal discomfort, acrocyanosis associated with hypotension and generalized edema. The presence of diffuse polyserositis was determined (hydropericardium with signs of cardiac tamponade, but without organic damage of the heart, bilateral pleurisy and minimal ascites), hormonal profile: TSH - 450 (0,17- 4,05 lU/ml), total T4- 30,2 (71,2-141 nmol/L). After performing two pericardiocentesis and active drainage of the pericardial cavity and initiating therapy with Levothyroxin 150 mcg and diuretics, she was discharged in a satisfactory condition with considerable changes in the hormones freeT4: 18 (12-22 pmol/l); TSH: 102 mlU/ml. This case illustrates the special challenges in establishing the correct diagnosis and therapeutic management of complications of severe hypothyroidism in patients with Down syndrome, such as myxedema and hydropericardium with cardiac tamponade. For this reason, increased vigilance in this category of patients and regular annual screening of thyroid dysfunctions will reduce the incidence of severe cases of thyroid pathology.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 18-23
Open AccessManagementul unui caz de hipotiroidism sever complicat cu efuziune pericardică masivă recidivantă în sindrom Down
Down’s syndrome is frequently associated with various endocrine dysfunctions, the most common being thyroid function disorders presented through a wide spectrum of manifestations, such as congenital and acquired hypothyroidism, especially the subclinical form, and less often hyperthyroidism. Symptoms of hypothyroidism are practically absent in subclinical forms, which requires regular screening for early detection of thyroid dysfunctions. We present of a clinical case from the Endocrinology Department of the „Timofei Moșneaga” Republican Clinical Hospital, successfully resolved following a multidisciplinary approach. The 25-year-old patient, diagnosed with Down syndrome since the age of 4, hospitalized in serious condition due to difficulty breathing, wet cough, dyspnea on moderate exertion, abdominal discomfort, acrocyanosis associated with hypotension and generalized edema. The presence of diffuse polyserositis was determined (hydropericardium with signs of cardiac tamponade, but without organic damage of the heart, bilateral pleurisy and minimal ascites), hormonal profile: TSH - 450 (0,17- 4,05 lU/ml), total T4- 30,2 (71,2-141 nmol/L). After performing two pericardiocentesis and active drainage of the pericardial cavity and initiating therapy with Levothyroxin 150 mcg and diuretics, she was discharged in a satisfactory condition with considerable changes in the hormones freeT4: 18 (12-22 pmol/l); TSH: 102 mlU/ml. This case illustrates the special challenges in establishing the correct diagnosis and therapeutic management of complications of severe hypothyroidism in patients with Down syndrome, such as myxedema and hydropericardium with cardiac tamponade. For this reason, increased vigilance in this category of patients and regular annual screening of thyroid dysfunctions will reduce the incidence of severe cases of thyroid pathology.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 46-50
Evaluarea riscului cardiometabolic la femeile de vârstă fertilă cu obezitate. date preliminare
Obesity is a chronic disease with extensive health consequences. Its prevalence is constantly increasing, including among children and young people. In this study we assessed the cardiometabolic risk and its correlation with leptin/adiponectin ratio in obese young women. We enrolled 72 apparently healthy women, comprising 36 with normal weight (BMI ≤ 25 kg/m²) and 36 with obesity (BMI ≥ 30 kg/m²). The mean age was 34.1±5.6 years. Clinical and paraclinical parameters were studied: body mass index (BMI), waist and hip circumference, waist-hip ratio, blood presure, serum level of glucose, insulin, leptin, adiponectin, total cholesterol, HDL cholesterol, LDL cholesterol. Compared to normal weight women, obese women have had significantly higher levels of leptin, insulin and blood glucose (p < 0.001). But the level of adiponectin was lower (p < 0.001). The leptin/adiponectin ratio had a positive correlation with BMI, waist circumferince, waist-hip ratio, blood glucose, insulinemia, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), LDL cholesterol and negative correlation with HDL cholesterol in the group of obese women. Research results revealed higher cardiometabolic risk in young women with obesity. The leptin/adiponectin ratio is in direct correlation with this risk, being a good predictor of insulin resistance.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 46-50
Open AccessEvaluarea riscului cardiometabolic la femeile de vârstă fertilă cu obezitate. date preliminare
Obesity is a chronic disease with extensive health consequences. Its prevalence is constantly increasing, including among children and young people. In this study we assessed the cardiometabolic risk and its correlation with leptin/adiponectin ratio in obese young women. We enrolled 72 apparently healthy women, comprising 36 with normal weight (BMI ≤ 25 kg/m²) and 36 with obesity (BMI ≥ 30 kg/m²). The mean age was 34.1±5.6 years. Clinical and paraclinical parameters were studied: body mass index (BMI), waist and hip circumference, waist-hip ratio, blood presure, serum level of glucose, insulin, leptin, adiponectin, total cholesterol, HDL cholesterol, LDL cholesterol. Compared to normal weight women, obese women have had significantly higher levels of leptin, insulin and blood glucose (p < 0.001). But the level of adiponectin was lower (p < 0.001). The leptin/adiponectin ratio had a positive correlation with BMI, waist circumferince, waist-hip ratio, blood glucose, insulinemia, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), LDL cholesterol and negative correlation with HDL cholesterol in the group of obese women. Research results revealed higher cardiometabolic risk in young women with obesity. The leptin/adiponectin ratio is in direct correlation with this risk, being a good predictor of insulin resistance.
- 1 April 2024
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 11 (1) , 27-31
Epidemiology of type 2 diabetes and prediabetes in the adult population of the Republic of Moldova (preliminary data)
Introduction. Type 2 DM accounts for over 95% of all diabetes cases worldwide and represents an important and independent cardio-metabolic risk factor. This is the first national study (Epidemiological study of widespread endocrine pathologies (diabetes, obesity) in the Republic of Moldova and its management strategy) that analyzes the prevalence of type 2 diabetes mellitus (DM), prediabetes, obesity, and dyslipidemia in the adult population of Moldova. Material and methods. This is an epidemiological cross-sectional study with cluster random sampling. A face-to-face interview was conducted with the participants using a pre-tested semi-structured questionnaire. All biochemical tests were performed in a certified laboratory. Statistical analysis used Spearman’s correlation test, chi-square, and Wilcoxon tests. The Research Ethics Committee of Nicolae Testemițanu State University of Medicine and Pharmacy (Minutes 3 from December 28 2020) approved this study. Results. 728 individuals were enrolled, of which 2.5% had unknown DM. Advanced age, obesity, and dyslipidemia were influencing factors for diabetes. 21.4% of participants had prediabetes, with a higher prevalence in men than in women (28.3 % versus 18.9 %). Only 23.2% of men and 30.4% of women had a BMI within the normal range. Abdominal circumference (AC) values greater than 102 cm and 88 cm in men and women, respectively, were determined in 39.4% of men and 53.8% of women. Conclusions. Our study showed an increased prevalence of carbohydrate metabolism disorders, including prediabetes, as well as a high prevalence of abdominal obesity. Persons with unknown diabetes mellitus have been identified.
- 1 April 2024
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 11 (1) , 27-31
Epidemiology of type 2 diabetes and prediabetes in the adult population of the Republic of Moldova (preliminary data)
Introduction. Type 2 DM accounts for over 95% of all diabetes cases worldwide and represents an important and independent cardio-metabolic risk factor. This is the first national study (Epidemiological study of widespread endocrine pathologies (diabetes, obesity) in the Republic of Moldova and its management strategy) that analyzes the prevalence of type 2 diabetes mellitus (DM), prediabetes, obesity, and dyslipidemia in the adult population of Moldova. Material and methods. This is an epidemiological cross-sectional study with cluster random sampling. A face-to-face interview was conducted with the participants using a pre-tested semi-structured questionnaire. All biochemical tests were performed in a certified laboratory. Statistical analysis used Spearman’s correlation test, chi-square, and Wilcoxon tests. The Research Ethics Committee of Nicolae Testemițanu State University of Medicine and Pharmacy (Minutes 3 from December 28 2020) approved this study. Results. 728 individuals were enrolled, of which 2.5% had unknown DM. Advanced age, obesity, and dyslipidemia were influencing factors for diabetes. 21.4% of participants had prediabetes, with a higher prevalence in men than in women (28.3 % versus 18.9 %). Only 23.2% of men and 30.4% of women had a BMI within the normal range. Abdominal circumference (AC) values greater than 102 cm and 88 cm in men and women, respectively, were determined in 39.4% of men and 53.8% of women. Conclusions. Our study showed an increased prevalence of carbohydrate metabolism disorders, including prediabetes, as well as a high prevalence of abdominal obesity. Persons with unknown diabetes mellitus have been identified.
- Open Access
- 1 February 2023
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 74 (3) , 200-204
Hypothyroidism induced by antituberculosis drugs
Tuberculosis is an infectious disease that affects practically all organs, including the thyroid gland. In the same time, the hypofunction of the thyroid gland may increase susceptibility to infection with Mycobacterium tuberculosis. Antituberculosis treatment, especially with second-line drugs, can lead to hypothyroidism. It has been found that rifampicin, ethionamide, prothionamide and para-aminosalicylic acid are among the most common antituberculosis drugs responsible for the development of hypothyroidism. These preparations/agents can cause thyroid dysfunction by increasing the metabolism and clearance of thyroid hormones by inducing cytochrome P-450 enzymes, deregulating/ iodine uptake and synthesis of thyroid hormones, altering hormone receptor action and intracellular signal transduction. The treatment with these medications requires the monitoring of the function of the thyroid gland during the treatment, especially in the first 3 months, but also in the post-treatment period. The installation of clinical and/or subclinical hypothyroidism will require the use of appropriate doses of levothyroxine during antituberculosis treatment.
- 1 February 2023
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 74 (3) , 200-204
Open AccessHypothyroidism induced by antituberculosis drugs
Tuberculosis is an infectious disease that affects practically all organs, including the thyroid gland. In the same time, the hypofunction of the thyroid gland may increase susceptibility to infection with Mycobacterium tuberculosis. Antituberculosis treatment, especially with second-line drugs, can lead to hypothyroidism. It has been found that rifampicin, ethionamide, prothionamide and para-aminosalicylic acid are among the most common antituberculosis drugs responsible for the development of hypothyroidism. These preparations/agents can cause thyroid dysfunction by increasing the metabolism and clearance of thyroid hormones by inducing cytochrome P-450 enzymes, deregulating/ iodine uptake and synthesis of thyroid hormones, altering hormone receptor action and intracellular signal transduction. The treatment with these medications requires the monitoring of the function of the thyroid gland during the treatment, especially in the first 3 months, but also in the post-treatment period. The installation of clinical and/or subclinical hypothyroidism will require the use of appropriate doses of levothyroxine during antituberculosis treatment.